Dimension Capital

Stately Bio operates in stealth mode and focuses on advancing the understanding of cellular dynamics through its innovative technology. The company has developed patented machine learning methods that allow for the measurement of cell identity, behavior, and maturation through live-cell, label-free imaging. This approach enables researchers to gain insights into cells while maintaining their viability, providing a valuable tool for various applications in biological research and medicine.

Achira combines AI and physics-based simulations to create high-fidelity, scalable models for molecular dynamics, generating synthetic data to improve drug discovery.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, focused on 3D bioprinting and tissue engineering. Founded in 2013, it develops bioprinted tissue therapeutics aimed at transforming disease treatment. The company utilizes proprietary microfluidic 3D bioprinting technology to create physiologically relevant living tissues, allowing for precise control over biomaterial composition and structure during fabrication. Aspect Biosystems offers contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical firms and academic institutions engaged in research related to respiratory diseases. Through partnerships with leading researchers and industry innovators, the company aims to address significant challenges in regenerative medicine and advance the understanding of human tissue creation for medical research and therapeutic discovery.

KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.

Automata is an automation company focused on transforming the life sciences sector through the use of robotic technology. By providing simple and affordable robotic devices, Automata enables laboratories and other organizations to enhance their capabilities in innovation, diagnosis, and discovery. The company’s robots are designed to be easily reconfigurable, allowing users to adapt them for various tasks. This accessibility empowers professionals in laboratories, classrooms, and production environments to integrate robotic automation seamlessly into their processes, facilitating quicker results and improved efficiency.

NewLimit focuses on the development of therapies aimed at treating age-related diseases and enhancing human health span. The company utilizes epigenetic reprogramming techniques and single-cell sequencing to rejuvenate tissues across the body. By addressing significant unmet medical needs, NewLimit aims to reverse aspects of the aging process and improve life expectancy, positioning itself at the forefront of anti-aging technology.

Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Kaleidoscope is a collaborative, cloud-based research platform for organizing and tracking scientific activities.

Lamin Labs is a Munich-based company founded in 2022 that focuses on providing data infrastructure for the field of biology. The company aims to streamline collaboration among data scientists and engineers by creating a unified data layer for research and development teams of all sizes. By integrating wet and dry laboratories, personnel, artificial intelligence, and various data sources, Lamin Labs seeks to transform R&D data management in a manner similar to how Git and GitHub revolutionized code collaboration. Additionally, the company develops data application programming interfaces that leverage machine learning algorithms to enhance data and analysis management, offering tools for both dry lab workspaces and educational platforms within the biotechnology sector.

NewLimit focuses on the development of therapies aimed at treating age-related diseases and enhancing human health span. The company utilizes epigenetic reprogramming techniques and single-cell sequencing to rejuvenate tissues across the body. By addressing significant unmet medical needs, NewLimit aims to reverse aspects of the aging process and improve life expectancy, positioning itself at the forefront of anti-aging technology.

Accelerate drug time to market through real study traceability and unparalleled trial integrity